MDNA.TO · Medicenna Therapeutics Corp.
Canada · RS rating 45 · As of 2026-10-14
| Price | 0.44 CAD |
|---|---|
| 1-day change | +1.1% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 86 / 88 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 14 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +73.2% |
| Market cap (USD) | $28.2M |